| Host: |
Rabbit |
| Applications: |
WB/IHC |
| Reactivity: |
Human/Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Low-density lipoprotein receptor-related protein 3 (17-66 aa) is suitable for use in Western Blot and Immunohistochemistry research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-2000IHC-P 1:50-300 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
LRP3 |
| Gene ID: |
4037 |
| Uniprot ID: |
LRP3_HUMAN |
| Immunogen Region: |
17-66 aa |
| Specificity: |
LRP3 Polyclonal Antibody detects endogenous levels of LRP3 protein. |
| Immunogen: |
The antiserum was produced against synthesized peptide derived from the human LRP3 at the amino acid range 17-66 |
| Function | Probable receptor, which may be involved in the internalization of lipophilic molecules and/or signal transduction. Its precise role is however unclear, since it does not bind to very low density lipoprotein (VLDL) or to LRPAP1 in vitro. |
| Protein Name | Low-Density Lipoprotein Receptor-Related Protein 3Lrp-3105 Kda Low-Density Lipoprotein Receptor-Related ProteinHlrp105 |
| Cellular Localisation | MembraneSingle-Pass Type I Membrane ProteinCoated Pit |
| Alternative Antibody Names | Anti-Low-Density Lipoprotein Receptor-Related Protein 3 antibodyAnti-Lrp-3 antibodyAnti-105 Kda Low-Density Lipoprotein Receptor-Related Protein antibodyAnti-Hlrp105 antibodyAnti-LRP3 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
